Charlene Santos

Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex

Jon S. Zawistowski, Samantha M. Bevill, Daniel R. Goulet et al. · Cancer Discovery · 2017 · 185 citations

Medicine, Oncology, Pharmacology +16

Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models

Gina Song, David B. Darr, Charlene Santos et al. · Clinical Cancer Research · 2014 · 94 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer

Carey K. Anders, Bárbara Adamo, Olga Karginova et al. · PLoS ONE · 2013 · 88 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer

Samantha M. Bevill, José F. Olivares-Quintero, Noah Sciaky et al. · Molecular Cancer Research · 2019 · 77 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of <i>BRCA</i> -Mutated and <i>BRCA</i> –Wild-Type Triple-Negative Breast Cancer

Olga Karginova, Marni B. Siegel, Amanda E.D. Van Swearingen et al. · Molecular Cancer Therapeutics · 2015 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17